Cargando…
Recurrent Glioblastomas Exhibit Higher Expression of Biomarkers with Stem-like Properties
BACKGROUND: Despite advances in the treatment of glioblastoma (GBM), the prognosis of patients continues to remain dismal. This unfavorable prognosis is mainly attributed to the tumor's propensity for progression and recurrence, which in turn is due to the highly aggressive nature of the persis...
Autores principales: | Nandeesh, B. N., Naskar, Sharmistha, Shashtri, Arun H., Arivazhagan, A., Santosh, Vani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812166/ https://www.ncbi.nlm.nih.gov/pubmed/29456350 http://dx.doi.org/10.4103/jnrp.jnrp_417_17 |
Ejemplares similares
-
Serum biomarkers identification by iTRAQ and verification by MRM: S100A8/S100A9 levels predict tumor-stroma involvement and prognosis in Glioblastoma
por: Arora, Anjali, et al.
Publicado: (2019) -
Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription
por: Nawaz, Zahid, et al.
Publicado: (2016) -
PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA
por: Nawaz, Zahid, et al.
Publicado: (2016) -
Epigenetically silenced GNG4 inhibits SDF1α/CXCR4 signaling in mesenchymal glioblastoma
por: Pal, Jagriti, et al.
Publicado: (2016) -
Genetic landscape of long noncoding RNA (lncRNAs) in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma
por: Paul, Yashna, et al.
Publicado: (2018)